Why the study?
Molecular-level alterations specific to ischemic myocardium and their potential to reflect disease severity or therapeutic outcome remain unclear.
Does the right atrial appendage transcriptome reflect disease severity and surgical outcomes in patients with ischemic heart disease?
Observational (n=483)
Yes
Does the right atrial appendage transcriptome reflect disease severity and surgical outcomes in patients with ischemic heart disease?
Answers are grounded in this paper and cite their sources.
Ischemic heart disease induces specific transcriptomic changes in the right atrial appendage that correlate with coronary disease complexity and functional recovery after bypass surgery.
Background: Although many pathological changes have been associated with ischemic heart disease (IHD), molecular-level alterations specific to the ischemic myocardium and their potential to reflect disease severity or therapeutic outcome remain unclear. Currently, diagnosis occurs relatively late and evaluating disease severity is largely based on clinical symptoms, various imaging modalities, or the determination of risk factors. This study aims to identify IHD-associated signature RNAs from the atrial myocardium and evaluate their ability to reflect disease severity or cardiac surgery outcomes. Methods and Results: We collected right atrial appendage (RAA) biopsies from 40 patients with invasive coronary angiography (ICA)-positive IHD undergoing coronary artery bypass surgery and from 8 patients ICA-negative for IHD (non-IHD) undergoing valvular surgery. Following RNA sequencing, RAA transcriptomes were analyzed against 429 donors from the GTEx project without cardiac disease. The IHD transcriptome was characterized by repressed RNA expression in pathways for cell–cell contacts and mitochondrial dysfunction. Increased expressions of the CSRNP3, FUT10, SHD, NAV2-AS4, and hsa-mir-181 genes resulted in significance with the complexity of coronary artery obstructions or correlated with a functional cardiac benefit from bypass surgery. Conclusions: Our results provide an atrial myocardium-focused insight into IHD signature RNAs. The specific gene expression changes characterized here, pave the way for future disease mechanism-based identification of biomarkers for early detection and treatment of IHD.
No takes yet. Share an insight, caveat, or question.
Mulari et al. (2021) conducted an observational in Ischemic Heart Disease (n=483). Ischemic heart disease vs. Non-ischemic heart disease and healthy donors was evaluated on Differentially expressed genes (DEGs) in the right atrial appendage transcriptome.
Synapse has enriched 10 related papers. Consider them for comparative context: